Literature DB >> 18164940

Psychiatric disorders in hypertrophic cardiomyopathy.

John F Morgan1, Ann C O'Donoghue, William J McKenna, Martin M Schmidt.   

Abstract

OBJECTIVE: Depression is undertreated in cardiac disease. Our aim was to evaluate frequency and risk factors of psychiatric disorders in hypertrophic cardiomyopathy.
METHODS: This was a two-phase epidemiological approach, using screening questionnaire then gold standard structured clinical interview. A cohort of 148 patients aged > or =18 (78% response rate) attending a dedicated hypertrophic cardiomyopathy clinic (1996-1998) were screened for psychiatric morbidity using Hospital Anxiety and Depression Scale and Social Adjustment Scale. Likely cases and noncases were evaluated by Structured Clinical Interview for DSM-III-R. The main outcome measure was prevalence of psychiatric diagnoses, with descriptive comparison against population statistics.
RESULTS: Thirty-seven percent of cardiomyopathy patients fulfilled criteria for anxiety disorder and 21% for mood disorder. Presence of mood disorder was associated with chest pain [relative risk (RR) 4.5, 95% CI 2.8-17.5], older age (2.8, 1.4-5.6), higher perceived risk of death (5.4, 2.3-13.0), poorer social adjustment (2.1, 1.1-4.2) and problems with sexual relations (1.5, 1.2-3.6). Presence of anxiety disorders was associated with chest pain (RR 3.5, 95% CI 2.1-26.0), higher perceived risk of death (2.0, 1.2-3.4), perception of physical symptoms as 'severe' (2.2, 1.2-4.2) and more recent diagnosis (1.7, 1.0-2.7).
CONCLUSIONS: Patients with cardiomyopathy have an elevated risk of mood disorders and anxiety disorders. Several demographic and clinical factors were found to be associated with these psychiatric conditions. Proper treatment intervention is likely to improve quality of life.

Entities:  

Mesh:

Year:  2008        PMID: 18164940     DOI: 10.1016/j.genhosppsych.2007.09.005

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  5 in total

1.  Impediments to DNA testing and cascade screening for hypertrophic cardiomyopathy and Long QT syndrome: a qualitative study of patient experiences.

Authors:  Andrew Smart
Journal:  J Genet Couns       Date:  2010-08-03       Impact factor: 2.537

Review 2.  At the Heart of the Pregnancy: What Prenatal and Cardiovascular Genetic Counselors Need to Know about Maternal Heart Disease.

Authors:  Ana Morales; Dawn C Allain; Patricia Arscott; Emily James; Gretchen MacCarrick; Brittney Murray; Crystal Tichnell; Amy R Shikany; Sara Spencer; Sara M Fitzgerald-Butt; Jessica D Kushner; Christi Munn; Emily Smith; Katherine G Spoonamore; Harikrishna S Tandri; W Aaron Kay
Journal:  J Genet Couns       Date:  2017-03-10       Impact factor: 2.537

3.  Pathogenesis of depression- and anxiety-like behavior in an animal model of hypertrophic cardiomyopathy.

Authors:  Amanda M Dossat; Marcos A Sanchez-Gonzalez; Andrew P Koutnik; Stefano Leitner; Edda L Ruiz; Brittany Griffin; Jens T Rosenberg; Samuel C Grant; Francis D Fincham; Jose R Pinto; Mohamed Kabbaj
Journal:  FASEB J       Date:  2017-02-24       Impact factor: 5.191

4.  Anxiety Predicts Poor Prognosis in Patients With Hypertrophic Cardiomyopathy.

Authors:  Chao-Jie He; Chang-Lin Zhai; Shao-Dai Huang; Hong-Yan Fan; Ye-Zhou Qian; Chun-Yan Zhu; Hui-Lin Hu
Journal:  Front Cardiovasc Med       Date:  2022-05-19

5.  Family-based associations in measures of psychological distress and quality of life in a cardiac screening clinic for inheritable cardiac diseases: a cross-sectional study.

Authors:  Catherine McGorrian; Charlene McShane; Colin McQuade; Ted Keelan; Jim O Neill; Joseph Galvin; Kevin Malone; Niall G Mahon; Mary Codd
Journal:  BMC Med Genet       Date:  2013-01-08       Impact factor: 2.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.